Literature DB >> 12516804

Histologic evaluation and treatment outcome after sequential radiofrequency ablation and hepatic resection for primary and metastatic tumors.

Allen L Hoffman1, Sandy S Wu, Amal K Obaid, Samuel W French, Juan Lois, Michael McMonigle, Hector C Ramos, Linda S Sher, Richard R Lopez.   

Abstract

Operative manipulation during hepatic resection (HR) causes tumor cell shedding which is a factor in disease recurrence. Radiofrequency ablation (RFA) causes coagulative necrosis and was used to destroy the tumor before HR. We evaluated tumor necrosis and recurrence of hepatic malignancies treated by sequential RFA/HR. A retrospective review of patients treated with sequential RFA/HR from April 1999 to January 2002 was performed. A Radionics 500-kW RF generator was used to ablate lesions via H2O-cooled electrodes under ultrasound guidance. Segmental HR was performed after RFA. Resected specimens were reviewed with hematoxylin and eosin staining and for apoptosis. Patient follow-up ranged from 10 to 33 months with evaluation of salient clinical, radiologic, and laboratory parameters. Seven patients (four male and three female) ages 62.1 +/- 10.3 years had sequential RFA/HR. Four patients had hepatocellular carcinoma (HCC) and three had colorectal metastases (CRm). The tumors were unifocal right-lobe lesions measuring 4.1 +/- 0.9 cm with a resection margin of 0.4 to 2.5 cm. Extensive necrosis was noted but intact nests of tumor cells occurred in all specimens with minimal apoptosis. Three of seven patients (two HCC and one CRm) developed pulmonary metastases at 3 to 20 months with one HCC patient developing concurrent liver metastases. Two deaths occurred in the HCC group. Sequential RFA/HR may minimize local recurrence; however, the high incidence of pulmonary metastases raises concern of transvenous migration. The histologic findings demonstrate foci of intact tumor cells after RFA. Controlled study of additional patients with long-term follow-up is necessary to better understand these findings.

Entities:  

Mesh:

Year:  2002        PMID: 12516804

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  7 in total

1.  Thermal ablation for unresectable liver tumours, time to move forward?

Authors:  Gianpiero Gravante
Journal:  World J Gastrointest Surg       Date:  2010-01-27

2.  Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study.

Authors:  Vincenzo Mazzaferro; Carlo Battiston; Stefano Perrone; Andrea Pulvirenti; Enrico Regalia; Raffaele Romito; Dario Sarli; Marcello Schiavo; Francesco Garbagnati; Alfonso Marchianò; Carlo Spreafico; Tiziana Camerini; Luigi Mariani; Rosalba Miceli; Salvatore Andreola
Journal:  Ann Surg       Date:  2004-11       Impact factor: 12.969

3.  Role of Pluronic block copolymers in modulation of heat shock protein 70 expression.

Authors:  Reshani H Perera; Tianyi M Krupka; Hanping Wu; Bryan Traughber; David Dremann; Ann-Marie Broome; Agata A Exner
Journal:  Int J Hyperthermia       Date:  2011       Impact factor: 3.914

4.  Role of Preoperational Imaging Traits for Guiding Treatment in Single ≤ 5 cm Hepatocellular Carcinoma.

Authors:  Mengchao Wei; Manxia Lin; Xian Zhong; Zihao Dai; Shunli Shen; Shaoqiang Li; Zhenwei Peng; Ming Kuang
Journal:  Ann Surg Oncol       Date:  2022-03-19       Impact factor: 4.339

5.  Radiofrequency ablation of hepatic tumours: effect of post-ablation margin on local tumour progression.

Authors:  Chang-Hsien Liu; Ronald S Arellano; Raul N Uppot; Anthony E Samir; Debra A Gervais; Peter R Mueller
Journal:  Eur Radiol       Date:  2009-09-16       Impact factor: 5.315

6.  Adjuvant Sorafenib Following Radiofrequency Ablation for Early-Stage Recurrent Hepatocellular Carcinoma With Microvascular Invasion at the Initial Hepatectomy.

Authors:  Meng-Chao Wei; Yao-Jun Zhang; Min-Shan Chen; Yong Chen; Wan-Yee Lau; Zhen-Wei Peng
Journal:  Front Oncol       Date:  2022-06-23       Impact factor: 5.738

7.  A prospective randomized study comparing radiofrequency ablation and hepatic resection for hepatocellular carcinoma.

Authors:  Hae Won Lee; Jeong Min Lee; Jung-Hwan Yoon; Yoon Jun Kim; Joong-Won Park; Sang-Jae Park; Seong Hoon Kim; Nam-Joon Yi; Kyung-Suk Suh
Journal:  Ann Surg Treat Res       Date:  2018-01-30       Impact factor: 1.859

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.